These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
516 related articles for article (PubMed ID: 18451253)
1. A novel transforming growth factor beta receptor kinase inhibitor, A-77, prevents the peritoneal dissemination of scirrhous gastric carcinoma. Kawajiri H; Yashiro M; Shinto O; Nakamura K; Tendo M; Takemura S; Node M; Hamashima Y; Kajimoto T; Sawada T; Ohira M; Hirakawa K Clin Cancer Res; 2008 May; 14(9):2850-60. PubMed ID: 18451253 [TBL] [Abstract][Full Text] [Related]
2. A novel molecular targeting compound as K-samII/FGF-R2 phosphorylation inhibitor, Ki23057, for Scirrhous gastric cancer. Nakamura K; Yashiro M; Matsuoka T; Tendo M; Shimizu T; Miwa A; Hirakawa K Gastroenterology; 2006 Nov; 131(5):1530-41. PubMed ID: 17101326 [TBL] [Abstract][Full Text] [Related]
3. Hypoxia upregulates adhesion ability to peritoneum through a transforming growth factor-beta-dependent mechanism in diffuse-type gastric cancer cells. Noda S; Yashiro M; Nshii T; Hirakawa K Eur J Cancer; 2010 Mar; 46(5):995-1005. PubMed ID: 20144860 [TBL] [Abstract][Full Text] [Related]
4. Fibrosis in the peritoneum induced by scirrhous gastric cancer cells may act as "soil" for peritoneal dissemination. Yashiro M; Chung YS; Nishimura S; Inoue T; Sowa M Cancer; 1996 Apr; 77(8 Suppl):1668-75. PubMed ID: 8608560 [TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of a TGFbeta receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells. Shinto O; Yashiro M; Kawajiri H; Shimizu K; Shimizu T; Miwa A; Hirakawa K Br J Cancer; 2010 Mar; 102(5):844-51. PubMed ID: 20145621 [TBL] [Abstract][Full Text] [Related]
6. A synergic inhibitory-effect of combination with selective cyclooxygenase-2 inhibitor and S-1 on the peritoneal metastasis for scirrhous gastric cancer cells. Tendo M; Yashiro M; Nakazawa K; Yamada N; Sawada T; Ohira M; Hirakawa K Cancer Lett; 2006 Dec; 244(2):247-51. PubMed ID: 16448745 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of nuclear factor-kappaB suppresses peritoneal dissemination of gastric cancer by blocking cancer cell adhesion. Mino K; Ozaki M; Nakanishi K; Haga S; Sato M; Kina M; Takahashi M; Takahashi N; Kataoka A; Yanagihara K; Ochiya T; Kamiyama T; Umezawa K; Todo S Cancer Sci; 2011 May; 102(5):1052-8. PubMed ID: 21288284 [TBL] [Abstract][Full Text] [Related]
8. Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Hippo Y; Yashiro M; Ishii M; Taniguchi H; Tsutsumi S; Hirakawa K; Kodama T; Aburatani H Cancer Res; 2001 Feb; 61(3):889-95. PubMed ID: 11221876 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness. Gaspar NJ; Li L; Kapoun AM; Medicherla S; Reddy M; Li G; O'Young G; Quon D; Henson M; Damm DL; Muiru GT; Murphy A; Higgins LS; Chakravarty S; Wong DH Mol Pharmacol; 2007 Jul; 72(1):152-61. PubMed ID: 17400764 [TBL] [Abstract][Full Text] [Related]
10. HIF-1α is a crucial factor in the development of peritoneal dissemination via natural metastatic routes in scirrhous gastric cancer. Miyake S; Kitajima Y; Nakamura J; Kai K; Yanagihara K; Tanaka T; Hiraki M; Miyazaki K; Noshiro H Int J Oncol; 2013 Nov; 43(5):1431-40. PubMed ID: 23970191 [TBL] [Abstract][Full Text] [Related]
11. The metastasis-associated microRNA miR-516a-3p is a novel therapeutic target for inhibiting peritoneal dissemination of human scirrhous gastric cancer. Takei Y; Takigahira M; Mihara K; Tarumi Y; Yanagihara K Cancer Res; 2011 Feb; 71(4):1442-53. PubMed ID: 21169410 [TBL] [Abstract][Full Text] [Related]
12. Cancer-associated fibroblasts might sustain the stemness of scirrhous gastric cancer cells via transforming growth factor-β signaling. Hasegawa T; Yashiro M; Nishii T; Matsuoka J; Fuyuhiro Y; Morisaki T; Fukuoka T; Shimizu K; Shimizu T; Miwa A; Hirakawa K Int J Cancer; 2014 Apr; 134(8):1785-95. PubMed ID: 24155219 [TBL] [Abstract][Full Text] [Related]
13. Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway. Yoo YA; Kang MH; Kim JS; Oh SC Carcinogenesis; 2008 Mar; 29(3):480-90. PubMed ID: 18174246 [TBL] [Abstract][Full Text] [Related]
14. ICAM-2 gene therapy for peritoneal dissemination of scirrhous gastric carcinoma. Tanaka H; Yashiro M; Sunami T; Sakate Y; Kosaka K; Hirakawa K Clin Cancer Res; 2004 Jul; 10(14):4885-92. PubMed ID: 15269165 [TBL] [Abstract][Full Text] [Related]
15. [Mechanisms responsible for the progression of scirrhous gastric cancer]. Yashiro M; Ohira M; Muguruma K; Shinto O; Hirakawa K Nihon Rinsho; 2012 Oct; 70(10):1812-6. PubMed ID: 23198567 [TBL] [Abstract][Full Text] [Related]
16. Adenoviral-mediated gene transduction of the hepatocyte growth factor (HGF) antagonist, NK4, suppresses peritoneal metastases of gastric cancer in nude mice. Ueda K; Iwahashi M; Matsuura I; Nakamori M; Nakamura M; Ojima T; Naka T; Ishida K; Matsumoto K; Nakamura T; Yamaue H Eur J Cancer; 2004 Sep; 40(14):2135-42. PubMed ID: 15341989 [TBL] [Abstract][Full Text] [Related]
17. Anti-transforming growth factor beta receptor II antibody has therapeutic efficacy against primary tumor growth and metastasis through multieffects on cancer, stroma, and immune cells. Zhong Z; Carroll KD; Policarpio D; Osborn C; Gregory M; Bassi R; Jimenez X; Prewett M; Liebisch G; Persaud K; Burtrum D; Wang S; Surguladze D; Ng S; Griffith H; Balderes P; Doody J; Schwartz JD; Youssoufian H; Rowinsky EK; Ludwig DL; Witte L; Zhu Z; Wu Y Clin Cancer Res; 2010 Feb; 16(4):1191-205. PubMed ID: 20145179 [TBL] [Abstract][Full Text] [Related]
18. Two distinct patterns of peritoneal involvement shown by in vitro and in vivo ovarian cancer dissemination models. Kishikawa T; Sakamoto M; Ino Y; Kubushiro K; Nozawa S; Hirohashi S Invasion Metastasis; 1995; 15(1-2):11-21. PubMed ID: 7545653 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of DNA methyltransferase by antisense oligodeoxynucleotide modifies cell characteristics in gastric cancer cell lines. Saikawa Y; Kubota T; Maeda S; Otani Y; Kumai K; Kitajima M Oncol Rep; 2004 Sep; 12(3):527-31. PubMed ID: 15289832 [TBL] [Abstract][Full Text] [Related]
20. Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers. Sakakura C; Hasegawa K; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Yazumi S; Yamagishi H; Okanoue T; Chiba T; Hagiwara A Clin Cancer Res; 2005 Sep; 11(18):6479-88. PubMed ID: 16166423 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]